ROMIDEPSIN

romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack

ROMIDEPSIN (15405T)

romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack
15405T
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required

Restriction

Indication: Relapsed or chemotherapy refractory Peripheral T-cell Lymphoma
Treatment phase: Continuing treatment

Restriction

Indication: Relapsed or chemotherapy refractory Peripheral T-cell Lymphoma
Treatment phase: Grandfather arrangement - Transitioning from non-PBS-subsidised treatment
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 40 mg # of repeats: 8 DPMA: $5,101.15 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
ROMIDEPSIN-REACH
(romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack)